The dynamics of selected local inflammatory markers to talc in the treatment of malignant pleural effusions

被引:5
|
作者
Habal, Petr [1 ,2 ]
Jankovicova, Karolina [2 ,3 ]
Omran, Nedal [1 ,2 ]
Kondelkova, Katerina [2 ,3 ]
Krejsek, Jan [2 ,3 ]
Mandak, Jiri [1 ,2 ]
机构
[1] Charles Univ Prague, Fac Med Hradec Kralove, Dept Cardiac Surg, Prague, Czech Republic
[2] Univ Hosp, Hradec Kralove, Czech Republic
[3] Charles Univ Prague, Fac Med Hradec Kralove, Dept Clin Immunol & Allergy, Prague, Czech Republic
来源
BIOMEDICAL PAPERS-OLOMOUC | 2013年 / 157卷 / 04期
关键词
malignant pleural effusion; thoracoscopy; talc; sCD-163; sTLR-2; TOLL-LIKE RECEPTORS; EXPRESSION; PLEURODESIS; SURVIVAL; PATHOPHYSIOLOGY; MECHANISMS; CYTOKINES; IMMUNITY; POUDRAGE; FLUID;
D O I
10.5507/bp.2012.095
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background. Malignant pleural effusions accumulate in the space between the visceral (inner) layer covering the lungs and the parietal (outer) layer covering the chest wall. Larger effusions compress the pulmonary parenchyma resulting in increasing dyspnoea. Treatment is always local and palliative. Among others, chemical pleurodesis using talc can be performed in selected patients. Talc is hydrated magnesium silicate (chemically H2Mg3 (SiO3)(4)) and has been used for pleurodesis since 1935. Videothoracoscopic talc powder insufflation (talc poudrage) is the most effective. However, markers of inflammatory reactions to extraneous substances like talc are not fully understood. The aim of this study was to assess the course of local inflammatory changes in the pleural cavity after talc insufflation. Methods. The Department of Cardiac Surgery of the Faculty of Medicine and University Hospital in Hradec Kralove, treated 47 patients aged 65 on average; 29 males and 18 females with proven recurrent malignant pleural effusion of various aetiologies from January 2009 to December 2010. They were retrospectively divided into group A (40 patients) without recurring effusion, and group B (7 patients) with recurring effusion and the need for thoracentesis or chest drainage during the 9-month monitoring. Results. Major findings were made in soluble forms of cell receptors. Group B showed statistically higher levels of the anti-inflammatory form of sCD-163 receptor in pleural fluid before the talc poudrage. This showed limited ability to create an adequate inflammatory response to external stimuli. This group also showed lower levels of the inflammatory form of sTLR-2 receptor immediately after the talc insufflation. This revealed low local reactivity to external stimuli. The effect of the treatment was not influenced by morphologic tumour type. No statistically significant differences in postoperative complications were found. This confirmed the safety of both videothoracoscopy and treatment. Conclusions. There was no correlation between the type of malignant affection and the outcome of the chemical pleurodesis. Patients with relapsing effusion have higher values of concentration of anti-inflammatory sCD-163 in pleural fluid even before the application of talc, and lower levels of concentration of inflammatory sTLR-2 immediately after application of talc.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 50 条
  • [31] Malignant Pleural Effusions: Review of Treatment and Our Experience
    Bertolaccini, L.
    Zamprogna, C.
    Barberis, L.
    Navarra, M.
    Manno, E.
    D'Urso, A.
    Massaglia, F.
    REVIEWS ON RECENT CLINICAL TRIALS, 2007, 2 (01) : 21 - 25
  • [32] Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions
    Zimmer, PW
    Hill, M
    Casey, K
    Harvey, E
    Low, DE
    CHEST, 1997, 112 (02) : 430 - 434
  • [33] Pleurodesis in Patients with Malignant Pleural Effusions: Talc Slurry or Bleomycin? Results of a Prospective Randomized Trial
    Fabio José Haddad
    Riad Naim Younes
    Jefferson Luiz Gross
    Daniel Deheinzelin
    World Journal of Surgery, 2004, 28 : 749 - 752
  • [34] Increased Pleural Fluid Adenosine Deaminase Levels in Patients with Malignant Pleural Effusions: A Potential Predictor of Talc Pleurodesis Outcome
    Huseyin Yildirim
    Muzaffer Metintas
    Güntülü Ak
    Sinan Erginel
    Fusun Alatas
    Emel Kurt
    Selma Metintas
    Irfan Ucgun
    Lung, 2007, 185 : 349 - 354
  • [35] Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: A potential predictor of talc pleurodesis outcome
    Yildirim, Huseyin
    Metintas, Muzaffer
    Ak, Guentuelue
    Erginel, Sinan
    Alatas, Fusun
    Kurt, Emel
    Metintas, Selma
    Ucgun, Irfan
    LUNG, 2007, 185 (06) : 349 - 354
  • [36] Evaluation of inflammatory cytokines in malignant and benign pleural effusions
    Alexandrakis, MG
    Coulocheri, SA
    Bouros, D
    Mandalaki, K
    Karkavitsas, N
    Eliopoulos, GD
    ONCOLOGY REPORTS, 2000, 7 (06) : 1327 - 1332
  • [37] The use of indwelling pleural catheters for the treatment of malignant pleural effusions
    Syer, Tom
    Walker, Steven
    Maskell, Nick
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (07) : 659 - 664
  • [38] Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial
    Mohsen, Tarek A.
    Abou Zeid, Amany A.
    Meshref, Mohamed
    Tawfeek, Nehad
    Redmond, Karen
    Ananiadou, Olga G.
    Haj-Yahia, Saleem
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 40 (02) : 282 - 286
  • [39] Perspective in predicting the effect of pleurodesis in the treatment of malignant pleural effusions
    Habal, P.
    Omran, N.
    Kovacicova, K.
    Chek, J.
    Jankovicova, K.
    Mandak, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2015, 116 (05): : 285 - 288
  • [40] Prospective randomized trial of silver nitrate vs talc slurry in pleurodesis for symptomatic malignant pleural effusions
    Paschoalini, MD
    Vargas, FS
    Marchi, E
    Pereira, JR
    Jatene, FB
    Antonangelo, L
    Light, RW
    CHEST, 2005, 128 (02) : 684 - 689